HelloBetter
HelloBetter is a leading European company for digital therapeutics in the field of mental health. It offers evidence-based online therapy courses that are covered by health insurance. With innovative solutions and a focus on research, HelloBetter improves mental health worldwide.
About HelloBetter
editHelloBetter is a leading European company in the field of digital therapeutics (DTx) for mental health and a global pioneer in digital mental health research. Founded in 2015, HelloBetter offers evidence-based online therapy courses that are available by prescription and covered by all statutory health insurance providers in Germany. These courses are available in German and provide support for mental health issues such as stress, depression, panic attacks, or sleep disorders.
Key Products and Services
editHelloBetter offers a variety of online courses specifically designed to address mental health issues. The courses are structured into 6 to 9 units, each lasting about an hour and can be flexibly integrated into daily life. Participants receive personal support from qualified psychologists or psychotherapists and individual feedback on their progress. The courses are recognized as digital health applications (DiGA) and can be prescribed by doctors or therapists.
Mission and Values
editThe mission of HelloBetter is to provide effective, accessible, and scalable solutions for mental health. The company is committed to addressing the global mental health crisis by using digital technologies to offer psychological support without waiting times. HelloBetter places great importance on scientific evidence and data protection, with all courses complying with the strictest data protection regulations.
Sustainability Goals and Initiatives
editHelloBetter is committed to developing sustainable digital health solutions that are accessible worldwide. The company recently secured 3 million euros for the research and development of a transdiagnostic digital solution that uses artificial intelligence to personalize the user experience and improve adherence as well as overall mental health outcomes. This initiative, known as "MindFIT," aims to create a modular and transdiagnostic model for mental health that offers flexible adaptability and personalization.
Current Developments
editIn 2023, HelloBetter received the Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for its digital therapeutic HelloBetter Panic. Additionally, the company was recognized as a technology pioneer in 2024 by the World Economic Forum, highlighting its role as an innovator in the field of digital health. HelloBetter has also entered the U.S. market with the brand HelloGina, which offers a sexual wellness program for individuals with vaginismus.
HelloBetter remains committed to making a positive impact on mental health worldwide by collaborating with political, business, and academic leaders and advancing the development of innovative solutions.